Stimulant Dosing Limits for ADHD: When Is The Adderall / Ritalin Dose Too High?

A clinical review examines the risks of high-dose stimulants and outlines maximum recommended doses for amphetamines and methylphenidate.

Stimulant Dosing Limits for ADHD: When Is The Dose Too High? Content written by: Chris Aiken, MD and Kelvin Quiñones-Laracuente, MD, PhD 💡Stimulant Max Dose Table: thecarlatreport.com/stimulantlimits ➡️Full Article: thecarlatreport.com/articles/4464-stimulant-dosing-limits 📖Medication Fact Book: thecarlatreport.com/produ... ================ Follow Carlat: 🔴SUBSCRIBE ► / @thecarlatreport ➡️Twitter: / CarlatPsych ================ 00:00 Intro 00:03 Challenge of Stimulant Dosing 00:43 Risks 01:55 Amphetamines 03:29 Methylphenidate 04:13 Dosing in Elderly 05:09 Practical Take-Aways 06:08 Carlat Verdict #ADHDMedications #StimulantDosing #AdderallRisks #ADHDHealth #StimulantSideEffects #ADHDTreatment #MentalHealthAwareness #ADHDEducation ================ In this comprehensive video, we delve into the critical topic of ADHD medications and the complexities surrounding stimulant dosing limits. For many individuals with ADHD, stimulant medications like Adderall and methylphenidate (Ritalin) can significantly improve focus, productivity, and overall functioning. In this video, we aim to break down where the safe upper limits lie, what to consider when increasing doses, and why crossing certain thresholds can lead to serious risks. We start by discussing why increasing stimulant doses beyond a certain point can be dangerous. Higher doses, while sometimes necessary for symptom control in severe cases, raise the risk of abuse, diversion, and cardiovascular issues, including hypertension, stroke, and myocardial infarction. We also explore the cognitive side effects of high doses, such as worsening sleep, a hyper-focused state that impairs the ability to switch tasks, and an increased risk of psychiatric symptoms like psychosis, mania, and anxiety. The video highlights key research findings, including a study on patients with narcolepsy who took doses nearly double the FDA maximum, resulting in a significant increase in psychiatric hospitalizations and substance abuse. Additionally, animal studies show alarming results, with brain damage observed in baboons given high doses of amphetamines equivalent to around 60 mg per day in humans. We then break down the FDA's guidelines for different stimulant medications, such as Adderall and methylphenidate, explaining the recommended maximum daily doses and when higher doses may be considered. For example, the FDA sets a maximum of 40 mg per day for Adderall in adults with ADHD, though in severe cases, doses up to 60 mg may be allowed. While some patients may benefit from the higher range, particularly in severe cases, this video strongly advises staying within the FDA-approved limits due to the lack of evidence supporting doses above 60 mg. We also cover extended-release options like Mydayis, which, though given at 50 mg, spreads the dose over 16 hours, creating a safer profile similar to Adderall XR at 40 mg. Next, we discuss the differences in dosing for